Should EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?CHIU, Chao-Hua; CHOU, Teh-Ying; CHIANG, Chi-Lu et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 4, pp 661-665, issn 0344-5704, 5 p.Article

Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: Preliminary reportCHIU, Chao-Hua; CHERN, Ming-Sheng; WU, Mei-Han et al.Journal of thoracic and cardiovascular surgery. 2003, Vol 125, Num 6, pp 1300-1305, issn 0022-5223, 6 p.Article

Combined epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor and chemotherapy in non-small-cell lung cancer: Chemo-refractoriness of cells harboring sensitizing-EGFR mutations in the presence of gefitinibTSAI, Chun-Ming; CHEN, Jen-Ting; CHIU, Chao-Hua et al.Lung cancer. 2013, Vol 82, Num 2, pp 305-312, issn 0169-5002, 8 p.Article

Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinibCHIU, Chao-Hua; SHIH, Yu-Ning; TSAI, Chun-Ming et al.Lung cancer. 2007, Vol 57, Num 2, pp 213-221, issn 0169-5002, 9 p.Article

Latent TB infection in newly diagnosed lung cancer patients ― A multicenter prospective observational studyFAN, Wen-Chien; TING, Wen-Ying; WU, Ming-Fang et al.Lung cancer. 2014, Vol 85, Num 3, pp 472-478, issn 0169-5002, 7 p.Article

Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWISTTSAI, Chih-Chien; CHEN, Yann-Jang; YEW, Tu-Lai et al.Blood. 2011, Vol 117, Num 2, pp 459-469, issn 0006-4971, 11 p.Article

Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancerLIN, Wei-Chun; CHIU, Chao-Hua; LIOU, Jia-Ling et al.Lung cancer. 2006, Vol 54, Num 2, pp 193-199, issn 0169-5002, 7 p.Article

Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicityCHIU, Chao-Hua; TSAI, Chun-Ming; CHEN, Yuh-Min et al.Lung cancer. 2005, Vol 47, Num 1, pp 129-138, issn 0169-5002, 10 p.Article

Mutation in thetyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non -small cell lung cancerCHOU, Teh-Ying; CHIU, Chao-Hua; LI, Ling-Hui et al.Clinical cancer research. 2005, Vol 11, Num 10, pp 3750-3757, issn 1078-0432, 8 p.Article

Erlotinib in patients with advanced lung squamous cell carcinomaCHIANG, Chi-Lu; TSAI, Chun-Ming; CHOU, Teh-Ying et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 1, pp 203-208, issn 0344-5704, 6 p.Article

IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cellsCHANG, Kuo-Ting; TSAI, Chun-Ming; CHIOU, Yih-Chy et al.American journal of physiology. Lung cellular and molecular physiology. 2005, Vol 33, Num 3, pp L446-L453, issn 1040-0605Article

Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancerCHANG, Kuo-Ting; HUANG, Chi-Ying F; TSAI, Chun-Ming et al.American journal of physiology. Lung cellular and molecular physiology. 2005, Vol 33, Num 3, pp L438-L445, issn 1040-0605Article